Thar Pharmaceuticals registers $50 million of stock for initial sale

Bookrunner SunTrust Robinson Humphrey will be assisting with offering

By Devika Patel

Knoxville, Tenn., Aug. 19 – Thar Pharmaceuticals, Inc. will price its initial public offering of common stock with a 30-day greenshoe, according to a Form S-1 filed Friday with the Securities and Exchange Commission. The company has registered up to $50 million of stock for the deal.

SunTrust Robinson Humphrey is the bookrunner.

Proceeds will be used for clinical trials, research and development, working capital and other general corporate purposes.

The biopharmaceutical company is based in Pittsburgh. The company intends to list its common stock on the Nasdaq under the symbol “THAR.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.